![Ryan Daws](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Daws
Plus aucun poste en cours
Fortune : - $ au 31/07/2026
Profil
Ryan Daws worked as Director at Cowen & Co. LLC.
from 2000 to 2009.
Mr. Daws worked as Director at Stifel, Nicolaus & Co., Inc. from 2010 to 2013.
Mr. Daws worked as Chief Financial Officer at Concert Pharmaceuticals, Inc. from 2014 to 2017.
Mr. Daws worked as Managing Director-Healthcare Investment Banking at Robert W.
Baird & Co., Inc. from 2017 to 2019.
Mr. Daws worked as CFO & Head-Business Development at Obsidian Therapeutics, Inc. from 2019 to 2023.
Mr. Daws worked as Chief Financial Officer at enGene Therapeutics, Inc. from 2023 to 2026.
Mr. Daws worked as Principal at Aptiv Services US LLC.
Education includes undergraduate studies at the University of South Carolina and an MBA from Darla Moore School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Anciens postes connus de Ryan Daws
| Sociétés | Poste | Fin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur Financier/CFO | 15/07/2026 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur Financier/CFO | 01/11/2023 |
Robert W. Baird & Co., Inc.
 Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Corporate Officer/Principal | 01/03/2019 |
| CONCERT PHARMACEUTICALS, INC. | Directeur Financier/CFO | 15/06/2017 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2013 |
Formation de Ryan Daws
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aptiv Services US LLC
 Aptiv Services US LLC Auto Parts: OEMProducer Manufacturing Manufactures automotive components | Producer Manufacturing |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert W. Baird & Co., Inc.
Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Finance |
Darla Moore School of Business
 Darla Moore School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
